(Q73030493)
Statements
Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors (English)
Kasper B
Fruehauf S
Schiedlmeier B
Buchdunger E
Ho AD